Optiver relies on BMLL market data for quant strategy

The market-maker has built its trading business on top of BMLL’s Level 3 data. But the collaboration is young, and the pair have grand plans to make options the next quant frontier.

Red screen with negative random floating numbers. Minus sign, loss, business and finance, illuminated figures, abstract data, futuristic, sciences, big data.

When firms weigh whether to buy or build a product, market data—especially of the real-time variety—often falls automatically into the “buy” bucket. But historical data is a different beast, and the work often falls on firms’ in-house teams to source such data from the various exchanges on which they transact. It is a large lift, and it’s often not scalable due to each exchange’s own quirks, says Edward Monrad, head of corporate strategy for Europe, the Middle East and Africa at Optiver.

Disappoi

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Study: RAG-based LLMs less safe than non-RAG

Researchers at Bloomberg have found that retrieval-augmented generation is not as safe as once thought. As a result, they put forward a new taxonomy to help firms mitigate AI risk.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here